Extensively Drug-Resistant Tuberculosis
"Extensively Drug-Resistant Tuberculosis" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Tuberculosis resistant to ISONIAZID and RIFAMPIN and at least three of the six main classes of second-line drugs (AMINOGLYCOSIDES; polypeptide agents; FLUOROQUINOLONES; THIOAMIDES; CYCLOSERINE; and PARA-AMINOSALICYLIC ACID) as defined by the CDC.
| Descriptor ID |
D054908
|
| MeSH Number(s) |
C01.252.410.040.552.846.775.500
|
| Concept/Terms |
Extensively Drug-Resistant Tuberculosis- Extensively Drug-Resistant Tuberculosis
- Extensively Drug Resistant Tuberculosis
- Extremely Drug-Resistant Tuberculosis
- Drug-Resistant Tuberculoses, Extremely
- Drug-Resistant Tuberculosis, Extremely
- Extremely Drug Resistant Tuberculosis
- Extremely Drug-Resistant Tuberculoses
- Tuberculoses, Extremely Drug-Resistant
- Tuberculosis, Extremely Drug-Resistant
- Tuberculosis, Extremely Drug Resistant
- XDR-TB
- Tuberculosis, Extensively Drug-Resistant
- Drug-Resistant Tuberculoses, Extensively
- Drug-Resistant Tuberculosis, Extensively
- Extensively Drug-Resistant Tuberculoses
- Tuberculoses, Extensively Drug-Resistant
- Tuberculosis, Extensively Drug Resistant
|
Below are MeSH descriptors whose meaning is more general than "Extensively Drug-Resistant Tuberculosis".
Below are MeSH descriptors whose meaning is more specific than "Extensively Drug-Resistant Tuberculosis".
This graph shows the total number of publications written about "Extensively Drug-Resistant Tuberculosis" by people in this website by year, and whether "Extensively Drug-Resistant Tuberculosis" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2013 | 1 | 0 | 1 |
| 2014 | 1 | 0 | 1 |
| 2015 | 0 | 1 | 1 |
| 2016 | 0 | 1 | 1 |
| 2017 | 11 | 2 | 13 |
| 2018 | 15 | 2 | 17 |
| 2019 | 2 | 1 | 3 |
| 2020 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Extensively Drug-Resistant Tuberculosis" by people in Profiles.
-
Extensively Drug-Resistant Tuberculosis in the Time of COVID-19-How has the Landscape Changed for Pakistan? Disaster Med Public Health Prep. 2020 08; 14(4):e9-e10.
-
Social Mixing and Clinical Features Linked With Transmission in a Network of Extensively Drug-resistant Tuberculosis Cases in KwaZulu-Natal, South Africa. Clin Infect Dis. 2020 05 23; 70(11):2396-2402.
-
Acquired Drug Resistance: Recognizing the Potential of Repurposed Drugs. Clin Infect Dis. 2019 11 13; 69(11):2038-2039.
-
A Color-conscious Diagnosis. Clin Infect Dis. 2019 09 13; 69(7):1259-1261.
-
Towards tailored regimens in the treatment of drug-resistant tuberculosis: a retrospective study in two Italian reference Centres. BMC Infect Dis. 2019 Jun 28; 19(1):564.
-
High treatment success rate for multidrug-resistant and extensively drug-resistant tuberculosis using a bedaquiline-containing treatment regimen. Eur Respir J. 2018 12; 52(6).
-
Genetic Characterization of Second-Line Drug-Resistant and Extensively Drug-Resistant Mycobacterium tuberculosis from the Northern Region of India. J Epidemiol Glob Health. 2018 12; 8(3-4):220-224.
-
Feature selection and prediction of treatment failure in tuberculosis. PLoS One. 2018; 13(11):e0207491.
-
Revising the definition of extensively drug-resistant tuberculosis. Lancet Respir Med. 2018 12; 6(12):893-895.
-
Spatial Patterns of Extensively Drug-Resistant Tuberculosis Transmission in KwaZulu-Natal, South Africa. J Infect Dis. 2018 11 05; 218(12):1964-1973.